Does 20 damage plus 10 more damage for each Energy attached to all Pokémon (both yours and your opponent's).
Discard 2 Energy attached to Blastoise. Choose 2 of your opponent's Benched Pokémon. This attack does 60 damage to each of them. (Don't apply Weakness and Resistance for Benched Pokémon.) Blastoise can't use Double Launcher during your next turn.
Platinum entered circulation in 2009. It belongs to the Platinum series.
The checklist contains 133 cards, placing it in a mid-size expansion range. As of 2026, the set is 17 years old and fits a legacy-era profile.
Blastoise (#2) is one of the Rare Holo prints in this expansion.
Blastoise is a Platinum card from the 2009 release window. Its card type is Pokémon.
The rarity label is Rare Holo. Printed HP is 130.
Energy typing is Water. This card evolves from Wartortle.
This card has the following ability: "Dig Well". The printed attacks highlight "Aqua Press" and "Double Launcher".
Blastoise (Platinum) is presently valued at about $36.93 in raw condition. Week-over-week change is limited (0.0%), indicating short-term stability.
That is close to the 30-day average of $36.40. Its 90-day trading band runs between $32.18 and $36.93, producing a 13% range and low-volatility behavior.
This version is categorized as Rare Holo.
Blastoise sits within a broader pool of Blastoise variants that can be compared by set, rarity, and price. Comparable entries in this snapshot: 6 cards, 6 distinct sets.
Observed alternatives run from $0.86 to $48.32 (5519% spread). The current card sits +151% versus the sampled alternative average of $14.74.
Notable alternatives include Blastoise #25 (Team Up) at $6.24, Blastoise #1 (POP Series 3), Blastoise #17 (Pokémon GO) at $0.86, and Blastoise #13 (HS—Unleashed) at $8.58.
Pricing context for collectors: We observe a 0.0% shift this week, which points toward price consolidation rather than immediate volatility. Observed 90-day bounds of $32.18 and $36.93 create a 13% band, matching a low-volatility profile.
Relative to the 30-day baseline ($36.40), pricing is near equilibrium. Condition sensitivity is substantial: PSA 10 carries a +133% premium over raw value.
PSA 9 is currently around $59.09, while PSA 10 is $86.00.
